The purpose of this study is to assess the validity and usefulness of omics signatures for improved identification and risk stratification of patients with endocrine hypertension and stratification of patients with primary hypertension.
Study Name: Omics Signature in the Diagnosis of Hypertension
Interventions: Other: omics
Locations: European Georges Pompidou Hospital, Paris, France|University of Padua, Padua, Italy; University of Torino, Torino, Italy; Raddboudumc, Nijmegen, Gelderland, Netherlands; University of Glasgow, Glasgow, United Kingdom
Study link: https://ClinicalTrials.gov/show/NCT02772315
To search for other studies by topic, location, or status, go to our Clinical Studies page.